Skip to content
lifestyle.mediatrainingforceos.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Surrozen, Inc.
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
October 20, 2026
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
October 2, 2026
Surrozen Submits IND for SZN-8141 to Treat Diabetic Macular Edema
September 8, 2026
Surrozen to Present at Upcoming Healthcare Investor Conferences
September 2, 2026
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Surrozen to Present at Upcoming Healthcare Investor Conference
July 15, 2026
Surrozen to Present at Upcoming Healthcare Investor Conference
May 12, 2026
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 28, 2026
Surrozen to Present at Upcoming Healthcare Investor Conference
February 11, 2026